Christine MD - MyoKardia Insider

MyoKardia Inc -- USA Stock  

USD 36.92  1.08  2.84%

Co-Founder

We currently do not have informatin regarding Christine MD. This executive tanure with MyoKardia Inc is not currenlty determined.
        
650-741-0900  http://www.myokardia.com

Management Efficiency

The company has return on total asset (ROA) of (9.55) % which means that it has lost $9.55 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (19.24) % meaning that it created substantial loss on money invested by shareholders.

Entity Summary

MyoKardia, Inc., a clinical stage biopharmaceutical company, engages in discovering, developing, and commercializing therapies for the treatment of serious and neglected rare cardiovascular diseases. MyoKardia Inc (MYOK) is traded on NASDAQ in USA. It is located in CALIFORNIA, U.S.A and employs 77 people. MyoKardia is listed under Pharmaceutical Products category by Fama And French industry classification.
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add MyoKardia Inc to your portfolio

Top Management

MyoKardia Inc Leadership Team
Eric Topol, Director
Sunil Agarwal, Director
Christine MD, Founder
Mark Perry, Director
June Lee, COO
Wendy Yarno, Director, MBA
Kevin Starr, Director
Jake Bauer, President, MBA
Joseph Lambing, President, Ph.D
Steven Chan, President
Mary Cranston, Director
Katherine Bowdish, Director
Robert McDowell, SVP, Ph.D
David Meeker, Director
Marc Semigran, Executive
Leslie Leinwand, Founder
Tassos Gianakakos, CEO, MBA
Charles Homcy, Director
Jonathan Fox, Executive, Ph.D
Kimberly Popovits, Director

Stock Performance

MyoKardia Performance Indicators